an26939098-8k.htm
 

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
__________

FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 

Date of Report (Date of earliest event reported):  October 22, 2012

AngioDynamics, Inc.
(Exact Name of Registrant as Specified in Charter)


Delaware
000-50761
11-3146460
     
(State or Other Jurisdiction of Incorporation)
(Commission File
Number)
(IRS Employer
Identification No.)

 
14 Plaza Drive, Latham, New York                        12110
 
(Address of Principal Executive Offices)                 (Zip Code)
 
(518) 798-1215
(Registrant’s telephone number, including area code)
 
 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
 
 
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))
 

 
 
 

Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(e)           AngioDynamics 2004 Stock and Incentive Award Plan

On October 22, 2012, AngioDynamics, Inc. (“AngioDynamics”) held its 2012 Annual Meeting of Shareholders (the “Annual Meeting”), at which AngioDynamics’ shareholders approved an amendment to the AngioDynamics, Inc. 2004 Stock and Incentive Award Plan to increase the total number of shares of common stock that may be offered under the plan from 4,750,000 to 5,750,000 shares.  The board of directors approved the amendment, subject to shareholder approval, on September 5, 2012.

The material features of the AngioDynamics, Inc. 2004 Stock and Incentive Award Plan are filed herewith as Exhibit 99.1 and incorporated herein by reference.  The above description of the AngioDynamics, Inc. 2004 Stock and Incentive Award Plan is qualified in its entirety by reference to the copy of such plan filed herewith as Exhibit 10.1 and incorporated herein by reference.

Also at the Annual Meeting, AngioDynamics’ shareholders approved an amendment to the AngioDynamics, Inc. Employee Stock Purchase Plan to increase the total number of shares of common stock that may be offered under the plan from 700,000 to 1,200,000 shares.  The board of directors approved the amendment, subject to shareholder approval, on September 5, 2012.

The material features of the AngioDynamics, Inc. Employee Stock Purchase Plan are filed herewith as Exhibit 99.2 and incorporated herein by reference.  The above description of the AngioDynamics, Inc. Employee Stock Purchase Plan is qualified in its entirety by reference to the copy of such plan filed herewith as Exhibit 10.2 and incorporated herein by reference.


Item 5.07 – Submission of Matters to a Vote of Security Holders.

(a)             AngioDynamics’ Annual Meeting was held on October 22, 2012.

(b)              Shareholders voted on the matters set forth below.
 
1. 
The nominees for election to the Board of Directors were elected, each as a Class III director to serve until the 2015 Annual Meeting of Shareholders, based upon the following votes:
 
 
Nominee
Votes For
Withheld
Broker Non Votes
David Burgstahler
30,408,064
729,169
2,510,147
       
Wesley E. Johnson, Jr.
30,771,973
365,260
2,510,147
 
 
 
 
 
 
 
       
Steven R. LaPorte
30,768,717
368,516
2,510,147
 
 
2.  
The proposal to ratify the appointment of PricewaterhouseCoopers LLP as AngioDynamics’ independent registered public accounting firm for the fiscal year ending May 31, 2013 was approved based upon the following votes:

Votes for approval
33,397,133
Votes against
167,325
Abstentions
82,922
There were no broker non-votes for this item.


3.  
The proposal to approve an amendment to the AngioDynamics, Inc. 2004 Stock and Incentive Award  Plan to increase the total number of shares of common stock that may be offered under the plan from 4,750,000 to 5,750,000 was approved based upon the following votes:

Votes for approval
28,587,239
Votes against
2,531,647
Abstentions
18,347
Broker non votes
2,510,147

4.  
The proposal to approve an amendment to the AngioDynamics, Inc. Employee Stock Purchase Plan to increase the total number of shares of common stock that may be offered under the plan from 700,000 to 1,200,000 was approved based upon the following votes:

Votes for approval
30,921,119
Votes against
197,520
Abstentions
18,594
Broker non votes
2,510,147

5.  
The proposal to approve, on an advisory basis, AngioDynamics’ overall executive compensation policies and procedures for its named executive officers was approved based upon the following votes:

Votes for approval
30,069,333
Votes against
608,605
Abstentions
459,295
Broker non votes
2,510,147


(c)       Not applicable.
    
 
(d)        Not applicable.

 
 
 
 
 

Item 9.01 – Financial Statements and Exhibits.

(d)               Exhibits.
 

 Exhibit No.
  
Description
     
10.1
  
AngioDynamics, Inc. 2004 Stock and Incentive Award Plan (as amended) (incorporated by reference to AngioDynamics’ Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on September 10, 2012).
 
10.2
  
AngioDynamics, Inc. Employee Stock Purchase Plan (as amended) (incorporated by reference to AngioDynamics’ Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on September 10, 2012).
 
99.1
 
99.2
  
Summary of the AngioDynamics, Inc. 2004 Stock and Incentive Award Plan (as amended).
 
Summary of the AngioDynamics, Inc. Employee Stock Purchase Plan (as amended).

 
 
 


SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
ANGIODYNAMICS, INC.
(Registrant)
  
       
       
Date: October 25, 2012
By:
/s/ D. Joseph Gersuk  
    D. Joseph Gersuk  
   
Executive Vice President and Chief Financial Officer
  





 
 
 

EXHIBIT INDEX

 Exhibit No.
  
Description
     
10.1
  
AngioDynamics, Inc. 2004 Stock and Incentive Award Plan (as amended) (incorporated by reference to AngioDynamics’ Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on September 10, 2012).
 
10.2
  
AngioDynamics, Inc. Employee Stock Purchase Plan (as amended) (incorporated by reference to AngioDynamics’ Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on September 10, 2012).
 
99.1
 
99.2
  
Summary of the AngioDynamics, Inc. 2004 Stock and Incentive Award Plan (as amended).
 
Summary of the AngioDynamics, Inc. Employee Stock Purchase Plan (as amended).